A Melegaro1, W J Edmunds, R Pebody, E Miller, R George. 1. Modelling and Economics Unit, Centre for Infections, 61 Colindale Avenue, Health Protection Agency, London NW9 5EQ, UK. alessia.melegaro@hpa.org.uk
Abstract
OBJECTIVE: To evaluate the potential impact of various pneumococcal conjugate vaccination strategies, it is critical to ascertain the pre-vaccination epidemiology and to have a detailed evaluation of the current burden of pneumococcal disease. METHOD: A variety of national data sources and GP sentinel surveillance systems were used to estimate the incidence, number of hospital admissions, deaths, and GP consultations due to pneumococcal disease in England and Wales. Clinical outcomes included pneumococcal meningitis, bacteraemia, pneumonia and otitis media. A statistical model was used to attribute GP consultation recorded as pneumonia and acute otitis media to specific aetiological causes when these were not recorded. RESULTS: The burden of pneumococcal disease is considerable, with incidence rates of both invasive and non-invasive disease peaking in children (<5 years) and in the elderly (75+ years). Around 5800 hospitalisations specifically mentioning Streptococcus pneumoniae are estimated to occur annually in England and Wales, almost 40,000 for lobar pneumonia and over 15,000 for otitis media. There may be an additional 70,000 GP consultations for pneumococcal related community acquire pneumonia and over 630,000 for otitis media. A significant proportion of hospitalisations and GP consultations for pneumococcal disease occur among high-risk groups, with over 80% of hospital admissions reporting more than one diagnosis.
OBJECTIVE: To evaluate the potential impact of various pneumococcal conjugate vaccination strategies, it is critical to ascertain the pre-vaccination epidemiology and to have a detailed evaluation of the current burden of pneumococcal disease. METHOD: A variety of national data sources and GP sentinel surveillance systems were used to estimate the incidence, number of hospital admissions, deaths, and GP consultations due to pneumococcal disease in England and Wales. Clinical outcomes included pneumococcal meningitis, bacteraemia, pneumonia and otitis media. A statistical model was used to attribute GP consultation recorded as pneumonia and acute otitis media to specific aetiological causes when these were not recorded. RESULTS: The burden of pneumococcal disease is considerable, with incidence rates of both invasive and non-invasive disease peaking in children (<5 years) and in the elderly (75+ years). Around 5800 hospitalisations specifically mentioning Streptococcus pneumoniae are estimated to occur annually in England and Wales, almost 40,000 for lobar pneumonia and over 15,000 for otitis media. There may be an additional 70,000 GP consultations for pneumococcal related community acquire pneumonia and over 630,000 for otitis media. A significant proportion of hospitalisations and GP consultations for pneumococcal disease occur among high-risk groups, with over 80% of hospital admissions reporting more than one diagnosis.
Authors: Alessia Melegaro; Yoon Hong Choi; Robert George; W John Edmunds; Elizabeth Miller; Nigel J Gay Journal: BMC Infect Dis Date: 2010-04-08 Impact factor: 3.090
Authors: Adrienne Morrow; Philippe De Wals; Geneviève Petit; Maryse Guay; Lonny James Erickson Journal: Can J Infect Dis Med Microbiol Date: 2007-03 Impact factor: 2.471
Authors: Daniela M Ferreira; Daniel R Neill; Mathieu Bangert; Jenna F Gritzfeld; Nicola Green; Adam K A Wright; Shaun H Pennington; Laura Bricio-Moreno; Laura Bricio Moreno; Adriana T Moreno; Eliane N Miyaji; Angela D Wright; Andrea M Collins; David Goldblatt; Aras Kadioglu; Stephen B Gordon Journal: Am J Respir Crit Care Med Date: 2013-04-15 Impact factor: 21.405
Authors: Catherine Weil-Olivier; Mark van der Linden; Iris de Schutter; Ron Dagan; Lorenzo Mantovani Journal: BMC Infect Dis Date: 2012-09-07 Impact factor: 3.090